Climb Bio, Inc. — Director's Dealing 2024

Nov 12, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Climb Bio, Inc. (CLYM)
CIK: 0001768446
Period of Report: 2024-11-11

Reporting Person: WILLIAMS DOUGLAS E (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-11-11	Stock Option (Right to Buy)	$4.06	A	20000	Acquired	2034-11-10	Common Stock (20000)	Direct
2024-11-11	Stock Option (Right to Buy)	$4.06	A	6291	Acquired	2034-11-10	Common Stock (6291)	Direct

Footnotes

F1: The shares underlying the option vest in equal monthly installments from November 8, 2024 (the "Vesting Commencement Date") until the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service.

F2: The shares underlying the option vest on the earlier of June 26, 2025 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continued service.